Our recent data in MM have also demonstrated that inhibition of APEX1 nuclease, a gene that drives genomic evolution in myeloma, increases cytotoxicity while inhibiting genomic instability caused by a chemotherapeutic agent42. Here, APEX1 is linked to plasma cell myeloma.